DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 022578
Email this page to a colleague
» See Plans and Pricing
NDA 022578 describes ZYRTEC ALLERGY, which is a drug marketed by J And J Consumer Inc and is included in two NDAs. It is available from two suppliers. Additional details are available on the ZYRTEC ALLERGY profile page.
The generic ingredient in ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
The generic ingredient in ZYRTEC ALLERGY is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 022578
| Tradename: | ZYRTEC ALLERGY |
| Applicant: | J And J Consumer Inc |
| Ingredient: | cetirizine hydrochloride |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 022578
Suppliers and Packaging for NDA: 022578
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022578 | NDA | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 50580-778 | 50580-778-24 | 4 BLISTER PACK in 1 CARTON (50580-778-24) > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| ZYRTEC ALLERGY | cetirizine hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 022578 | NDA | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 50580-782 | 50580-782-01 | 2 CARTON in 1 PACKAGE (50580-782-01) > 4 BLISTER PACK in 1 CARTON > 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 10MG | ||||
| Approval Date: | Sep 3, 2010 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
